| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  CES Works Innovations and far beyond CES WORKS group has three core businesses: research, development and innovation. CES Works is specialized in breakthrough innovation in fields as varied as o Aeronautics; o Space; o Naval; o Railway; o Vehicles; o Scientific experiments; Both for civil and military applications. Led by a highly motivated team with complementary skills, CES Works aims to help our customers imagine new profitable products and opportunities. Its major strategic edge: To approach the problem in a global way (leading scientific and technological opportunities, risks, customers / market expectations, innovative economic and financial approaches, methodologies of management and control … Type: | 3 | 3 | 1 | 6 |
 |  Collège doctoral de l'Université Grenoble Alpes [Automatic translation follows] Training through research The Doctoral College welcomes 3,000 doctoral students, 47% of whom are international, within its 13 doctoral schools. Spearheading the Université Grenoble Alpes, a world-class research university (Top 100 in the Shanghai ranking), the Doctoral College relies on an innovative and dynamic scientific ecosystem, with the presence in particular of research organizations (CEA, CNRS, Inria, Inserm, INRAE, IRD), the establishment of major European instruments (ESRF, ILL, EMBL, IRAM, EMFL) and its proximity to CERN, as well as those of large companies (ST, Schneider Electric, Air Liquide, Soitec, BD, Roche, POMA, Vicat, Trixell, ARaymond, PETZL, Sofradir, … Type: | 12 | 3 | 7 | 4 |
 | CANOE - Le Centre Technologique Nouvelle Aquitaine Composites & Matériaux Avancés [Automatic translation follows] CANOE is an R&T center created in 2008 at the initiative of the Nouvelle Aquitaine Regional Council. Our activities: development of composites and advanced materials (formulation, manufacturing processes and characterization) are spread over 6 technologies: - Thermoplastic & elastomer formulations - Fibers and carbon, - Thermoplastic composites and prepregs - Additive manufacturing - Surface treatment by printing - Characterization and NDT. Our objective: to support companies in the development of new technologies (product/process) using pilot equipment (TRL 3-6): R&D studies (feasibility studies, prototyping, scale-up, tests, etc.), cooperative projects, training activities. Our main customers and partners are recognized … Type: | 29 | 7 | 16 | 47 |
 | AIS Congress The major mAb Event in France ! The Antibody Industrial Symposium jointly organized by the scientific society LabEx MAbImprove and MabDesign, the French association of the Biotherapy Industrial sector.The AIS is the ideal conference for scientists, industrials, clinicians, and policy makers to exchange about therapeutic antibodies and more! mAbs, Immunotherapy, Industry, Innovation, Research, drugdiscovery, networking, and B2B Type: | 19 | 4 | 17 | 1 |
 | Corasso [Automatic translation follows] Support and inform people affected by cancer, or rare cancer, of the head or neck Head and neck cancers are little known and yet they are the 4th most common cancer location in France. For young patients or people with a healthy lifestyle, diagnosis is often late, limiting the chances of recovery and requiring heavy treatments. When remission is possible, patients must also often learn to live with serious functional and aesthetic after-effects. Corasso is a young association of patients with cancer, or rare cancers, of the head or neck. Its missions: - Provide support in the … Type: | 20 | 1 | 15 | 8 |
 |  ISIR - Institut des Systèmes Intelligents et de Robotique Laboratoire de recherche pluridisciplinaire rassemblant la robotique, les sciences du vivant et les sciences médicales. L'ISIR (Institut des Systèmes Intelligents et de Robotique) est une Unité Mixte de Recherche (UMR 7222) sous la tutelle de Sorbonne Université, du CNRS et de l’Inserm (ERL-U1150). Laboratoire de recherche pluridisciplinaire, il rassemble des chercheuses et chercheurs relevant de différentes disciplines des Sciences de l’Ingénieur et de l’Information ainsi que des Sciences du Vivant. ISIR (Institute of Intelligent Systems and Robotics) is a Joint Research Unit (UMR 7222) under the supervision of Sorbonne University, The French National Centre for Scientific Research (CNRS) and Inserm … Type: | 15 | 4 | 11 | 121 |
 | Biopredic International Biopredic International is committed to support Life Science Research by developing and distributing biological tools. We assist both academia and industries in drug development, drug discovery, cosmetic and chemical fields. Biopredic International delivers assays, tissues, cells and reagents including: > High quality hepatocytes (human and animal, fresh or cryopreserved) and other liver-derived products (microsomes, S9 fractions and cytosols) > Skin products (fresh or frozen), including human skin discs and skin sheets (full thickness, dermatomed, stratum corneum), skin cells (keratinocytes, fibroblasts), subcellular fractions... > Blood products, including whole blood, sera, plasma, PBMCs, lymphocytes, monocytes, dendritic cells, CD34... > And other products … Type: | 3 | 2 | 1 | 25 |
 | APS COATING SOLUTIONS Beyond the surface, your performance Our mission : bring a sustainable value to your parts. APS Coating Solutions is specialized in dry application technologies for surface treatment. From prototypes to very large series, APS COATING SOLUTIONS develops and applies the functional coatings best suited to prolong the performance of your mechanical parts, whatever their environment. Projection thermique, Pistolage peinture liquide, Pistolage peinture poudre, Zinc lamellaire, Fluoropolymères, Epoxy, Polyamide, Projection plasma, Cold spray, HVOF, Lubrifiants à sec, Teflon, Rilsan, and Halar | 6 | 0 | 6 | 56 |
 | Amplitude Laser Leading international manufacturer of ultrafast lasers for scientific, medical and industrial applications since 2001. Amplitude is a leading manufacturer of ultrafast lasers for scientific, medical and industrial applications. From ultrafast industrial fiber lasers to petawatt-class high intensity lasers, Amplitude is focused on helping its customers with advanced solutions. Amplitude offers a unique, distinct and large product portfolio: diode-pumped ultrafast solid-state lasers, ultra-high energy Ti:Sapphire ultrafast lasers and a full line of high energy solid state laser products. With three manufacturing locations in Bordeaux and Paris (France), and Milpitas, U.S.A., and an extensive network of support offices, more than 400 employees … Type: | 13 | 2 | 12 | 310 |
 | ENDOCONTROL Facilitate Surgery ENDOCONTROL specializes in robotic assistance for laparoscopic surgery. The company works with and for surgeons to develop “cobots” (collaborative robots) for laparoscopic procedures. ENDOCONTROL develops and distributes a range of products aiming to aid the surgeon in minimally invasive surgery: VIKY EP, a motorized endoscope positioner for laparoscopy, VIKY UP, a motorized uterus positioner, JAIMY, the first articulated robotized instrument for 5-mm incisions. A 10-year collaboration with surgeons, 3 product ranges on the market, and 150 robots currently in service worldwide Medical Device, Innovation Technology, Robotics, Surgery, Laparoscopy, Minimal Invasive Surgery, Dispositif Médical, and Chirurgie Robotique Type: | 4 | 0 | 3 | 5 |
 | Orikine Bio Orikine Bio is a pioneering biotech company dedicated to advancing the field of engineered cytokines with unparalleled biological features for the treatment of immune-mediated diseases. Our core mission is to unlock the untapped potential of cytokines, enabling us to offer transformative therapies that have the power to reshape the lives of patients around the globe. | 0 | 0 | 0 | 10 |
 | Skylark Lasers Delivering CW single frequency C-DPSS lasers with market-leading output powers from a compact footprint. Skylark Lasers is a leading-edge photonics company specialising in the development and production of ultra-stable CW single frequency C-DPSS lasers. Our lasers deliver high output power from a compact footprint to unlock new possibilities for our customers — helping you reveal the unseen, detect the imperceptible, and measure the unknown. DPSS Lasers, Single Frequency DPSS lasers, SLM lasers, CW DPSS, Holography, Spectroscopy, Quantum Technology, Photonics, Narrow Linewidth Lasers, Raman Spectroscopy, Lasers, 640 nm, 349 nm, 532 nm, Quantum Sensing, Flow Cytometry, Quantum Metrology, Diode Pumped Solid … Type: | 2 | 0 | 1 | 26 |
 | apoQlar medical Experience Collaborative Medicine apoQlar is the developer of a medical mixed reality platform that is transforming the way medicine is practiced, experienced, learned, and shared. VSI HoloMedicine® is a medically certified software platform that leverages the Microsoft HoloLens hardware to transform medical images, clinical workflows, and medical education into an interactive 3D mixed reality environment. Improve patient outcomes, augment the clinical experience for physicians, and educate the doctors-of-tomorrow on VSI HoloMedicine®. HoloMedicine® is a registered trademark of apoQlar GmbH in the following countries/regions: Brazil, China, EU, India, Indonesia, Malaysia, Singapore, United Kingdom, USA. Feature availability varies by license type and … Type: | 3 | 0 | 3 | 68 |
 | Delta.g Leveraging gravity to see the unseen Delta g is a quantum technology and gravity gradiometry company on a mission to make gravity sensing technology as ubiquitous as GPS, radar and telecoms. Spinning out from the University of Birmingham in 2023, our technology is the world’s first quantum technology based gravity gradient capability to successfully detect buried features from their gravity profile alone. Gravity sensors have the potential to impact much of todays world for the better; reducing traffic jams by eliminating unnecessary roadworks, a reliable navigation alternative to GPS and improving the environment through better monitoring and models. Limitations in … Type: | 2 | 0 | 2 | 9 |
 | Prolific Making diverse, high-quality data easily available to anyone, anywhere. Prolific helps dedicated research teams to collect the very highest-quality human-powered data - at scale - using our simple-to-use platform to target and manage participants from our diverse, vetted participant pool. The truth matters: the best decisions, and biggest discoveries, are built on the highest-quality data. And with the increasing proliferation of AI, access to reliable, diverse data to develop and train AI models has never been more important. Created by researchers for researchers, Prolific was founded to provide a better way for researchers and organizations to get high-quality human data … Type: | 17 | 2 | 13 | 388 |
 | MarinaTex Developing a new material from seafood waste and algae, designed as a planet conscious alternative to plastic films. Type: | 0 | 0 | 0 | 3 |
 | moi composites Composites made easy A visionary, dynamic team of experts transforming how strong, lightweight products in various sizes and shapes are made using our exclusive, patented 3D printing technology, Continuous Fiber Manufacturing. Additive Manufacturing, 3D Printing, and Composites Type: | 0 | 0 | 0 | 18 |
 | OrganOx Our mission is to save lives by making every donated organ count "Living Organs For Life" Transforming transplantation with the OrganOx metra®. A transportable, automated ex vivo liver perfusion device. The core technology employed by the OrganOx metra® has been in development for over 15 years. During this time both of the founders (Professor Peter Friend and Professor Constantin Coussios) have driven the development of organ preservation and maintenance, formerly at the University of Cambridge and latterly at the University of Oxford. OrganOx Limited was founded in April 2008 as a spin-out from the University of Oxford. Conventional cold preservation … Type: | 1 | 1 | 0 | 132 |
 | Optalysys Revolutionising data privacy and processing 🔒 Enabling a world of secure computing. Harnessing the power of light, we push the boundaries of what is possible in data security by bringing speed to always-encrypted data technology. Through optical computing, we accelerate Fully Homomorphic Encryption (FHE) beyond the capabilities of electrical computing, making secure data sharing and collaboration a reality for everyone, everywhere. To find out more, visit www.optalysys.com ✅ Join our unique community hub, the Innovation Lab, to develop your FHE skills with expert training, market insights, exclusive content and events. https://optalysys.com/register-for-innovation-lab/ 🔗 We are committed to building a home for … Type: | 1 | 0 | 1 | 44 |
 | Tenpoint Therapeutics Ltd Vision-restoring engineered cell-based therapeutics & in vivo reprogramming. Tenpoint Therapeutics is a vision-restoring engineered cell-based therapeutics company. We are embracing a new opportunity to fundamentally reshape the future for people with ocular diseases. We have an ambitious goal with global impact. Type: | 2 | 2 | 0 | 27 |
 | Motorguia [Automatic translation follows] All About Cars | 2 | 1 | 1 | 2 |
 | BEIT Solving hard problems on NISQ and on future Quantum Computers for real customers. Beit operates in quantum computing industry. Our mission is to control quantum computers with algorithms able to solve hard problems. We are open to the cooperation with quantum computers providers, together we will make quantum computing worthwhile. quantum computing, quantum alghoritms, and quantum physics Type: | 1 | 1 | 0 | 26 |
 | GRINN Full-cycle IoT & electronics design At GRINN, we focus on what we do best. As it happens, what we do best is design advanced hardware using cutting edge technologies and offer comprehensive project support. With us, you gain both quality of life and competitive advantage. The only thing that beats the awesomeness of our designs is the range of applications for which they can be used worldwide. We are a team of engineering specialists with the unique strength in a rapid delivery of high quality services. We are committed to delivering innovative designs which fit the needs of our customers … Type: | 1 | 0 | 1 | 62 |
 | HiProMine S.A. Sustainable and eco-friendly solutions to provide nutritious products based on novel protein source. HiProMine S.A. specializes in insect based raw materials production for livestock and companion animals. We offer high quality insect meal (dry form), insect pulp (fresh meat), and insect dried larvae, produced from Black Soldier Fly - Hermetia illucens. Our meals are dried and processed in low temperature which improves digestibility and nutritive values for animals. Our production is compliant with veterinary control standards, biosecurity, prevention of diseases, and GMP+/HACCP rules. All substrates used in insect rearing are vegetable based and GMO free. Looking to alternative and sustainable … Type: | 0 | 0 | 0 | 54 |
 | Iris.ai Research discovery with artificial intelligence Iris.ai is a world-leading, award-winning AI engine, co-founded by Anita Schjøll Abildgaard, Jacobo Elosua, and AI researcher Victor Botev. Our cross-European team is at the cutting edge of AI innovation, specializing in deep knowledge textual understanding, natural language processing (NLP), and large language models (LLMs). Our comprehensive tools empower researchers to conduct literature reviews, data extraction, document summarization, and competitive intelligence with remarkable efficiency, drastically reducing the time spent on manual tasks. We provide advanced AI infrastructure and tools—including the RSpaceTM Core, customizable Enterprise solutions, and Infrastructure API—designed to convert unstructured information into actionable insights. … Type: | 11 | 1 | 9 | 29 |
 | Parx Materials Bacteria are everywhere. We tend to see bacteria as our biggest enemies, yet they are also our biggest allies. Microorganisms are so numerous and endlessly adaptable that we will never be able to control them completely. In the past decades, we have come to understand microorganisms better and it convinced human beings to believe that by using biocides, antibiotics, and pesticides we might be able to get control over them. However, this has resulted in the exact opposite: bacteria and viruses developed further and adapted, making them resistant to our control attempts and technologies. Creating resistant superbugs and hard to … Type: | 0 | 0 | 0 | 3 |
 | QuTech Research institute for quantum computing & quantum internet At QuTech, we work on a radically new technology with world-changing potential. Our mission: to develop scalable prototypes of a quantum computer and an inherently safe quantum internet, based on the fundamental laws of quantum mechanics. Established by TU Delft and the Netherlands Organisation for Applied Scientific Research TNO, the focus at QuTech currently covers nearly all facets of quantum computing, including theoretical physics, new materials, quantum coding, and the actual development of (components of) a quantum computer. qubits, quantum computing, quantum internet, single-spin qubits, nanotechnology, electron spins, quantum mechanics, and quantum Type: | 2 | 0 | 2 | 202 |
 | VISUfarma - the eye health company Creating value in eye health for our patients worldwide VISUfarma is a pan-European ophthalmic pharmaceutical company with a clear mission: to bring quality products and global therapeutic innovation to European eye health. We are an ambitious and fast growing ophthalmology company, commercializing a broad portfolio of pharmaceutical products and medical devices across Europe. (www.VISUfarma.com). The company was formed in 2016 and is the result of the successful combination of the Italian company Visufarma SpA and the commercial activities of the international Nicox SA, headquartered in France. The combination created VISUfarma. We offer a complete portfolio of products in the areas … Type: | 0 | 0 | 0 | 99 |
 | LeydenJar The future is full of energy LeydenJar Technologies develops a 100% Silicon anode that boosts the energy density of Li-ion batteries for application in consumer electronics, automotive and specialty applications. Lithium Ion Batteries, Nanotechnology, Silicon anodes, and PECVD Type: | 9 | 2 | 7 | 94 |
 | The Hyve We enable open science by developing and implementing open source solutions and FAIRifying data in life sciences. The Hyve is the data & informatics service provider for life science organizations looking to align their data infrastructure with their research needs. We provide services regarding biomedical informatics solutions to most of the top 20 biotech and pharmaceutical companies, hospitals, universities, and medical centres in the United States and Europe, including Dana Farber Cancer Institute in Boston and King’s College London. We also collaborate with biobanks, registries, and patient organisations around the world. Our mission is to enable open science by developing … Type: | 6 | 0 | 6 | 48 |
 | Luxexcel - 3D printed lenses 3D printed prescription lenses #lenses #ophthalmic #3dprinting #augmentedreality #virtualreality #smartglasses Luxexcel is the pioneer in 3D printed lenses. Luxexcel has developed and owns all components necessary to enable our customers to 3D print optics. We provide our customers with a turn-key solution comprising of hardware, software, 3D printing process and materials to 3D print prescription lenses. Luxexcel is headquartered in Eindhoven with R&D and operations in Turnhout Belgium and sales and service in Alpharetta GA, USA. For additional information visit our website www.luxexcel.com Printoptical Technology, 3D Printing Optics, Ophthalmic Lenses, Additive Manufacturing, 3d printed lenses, lenses, smart glasses, augmented reality, … Type: | 3 | 2 | 1 | 8 |
 | Ampleon Advancing society through RF Created in 2015 and headquartered in the Netherlands, Ampleon is shaped by nearly 60 years of RF power leadership. The company envisions to advance society through innovative RF solutions based on GaN and LDMOS technologies. Ampleon is dedicated to being the partner of choice by delivering high-quality, high-performance RF products with its world-class talent. The portfolio offers flexibility in scaling design and production for any volume and addresses applications for 5G NR Infrastructure, Industrial, Scientific, Medical, Broadcast, Navigation and Safety Radio. Proven reliability, secure supply and excellent product consistency enable highest manufacturing yields for customers who … Type: | 1 | 0 | 0 | 829 |
 | LUMICKS Empowering scientists with tools that reveal crucial insights not available before, at the molecular and cellular level. LUMICKS is the leading supplier of dynamic single-molecule and cell avidity analysis instruments. Our instruments enable – for the first time – the analysis of complex dynamic details related to the behavior and interaction of single molecules and cells. Built upon innovative and Nobel Prize-winning technologies, such as optical tweezers (Nobel Prize for Physics 2018), and STED super-resolution (Nobel Prize for Chemistry 2014), our tools enable the understanding of life to the smallest detail. Our goal is to advance science and improve human … Type: | 4 | 2 | 2 | 175 |
 | ClearDetections Your partner in Plant Health Diagnostics! ClearDetections is a company specialized in development and commercialization of Plant Health Diagnostics solutions. Our focus relies on using molecular techniques such as Real-Time PCR for diagnostic of complex organisms such as nematodes and fungi. Besides our kits we work directly with customers to achieve taylor-made solutions for their Plant Health requests. Molecular Biology, Real-Time PCR, DNA extraction, nematodes, tr4, banana, panama disease, plant health, diagnostics, and molecular biology | 1 | 0 | 1 | 2 |
 | Bitonic Invest in bitcoin with ease. Bitcoin-only, no hypecoins. Bitonic has been at the forefront of Bitcoin adoption in the Netherlands since its establishment in 2012. As the first Bitcoin-only company in the country our mission has remained the same since the start: to make Bitcoin accessible to everyone. We are committed to seamlessly integrating Bitcoin into the financial ecosystem, and our goal is to provide our customers with the highest level of service, security, and convenience. Our services include: - Bitonic App and website: The easiest way to buy, sell and store bitcoin - Bits: create your own automated Bitcoin … Type: | 2 | 0 | 2 | 35 |
 | MedApp Nederland [Automatic translation follows] MedApp. The smart pharmacy. For a healthcare professional, the importance of adequate medication adherence is no secret. Unfortunately, around forty percent of patients fail to consistently administer medication. There are more than three hundred underlying causes, many of which can be classified as procrastination, forgetfulness or insufficient stock. MedApp gives medication users control over medication by offering a solution that actually works. Moreover, MedApp goes beyond the medication user by linking to the professional healthcare world. By registering medication intake, a healthcare provider can easily gain insight into the intake behavior within the population and a pharmacist … Type: | 0 | 0 | 0 | 64 |
 | Citryll Translating NET biology into novel therapies for inflammatory diseases Citryll has translated a deep understanding of the neutrophil extracellular trap (NET) pathway to therapeutically address its central role in a broad range of inflammatory diseases. With a unique dual mode of action, the company’s lead antibody, CIT-013, has reached the clinic by demonstrating a precise and powerful ability to control NETs and NETosis. Citryll is initially developing CIT-013 as a novel drug for rheumatoid arthritis and hidradenitis suppurativa, which may serve as enabling indications for a wide spectrum of inflammatory diseases. The initial clinical trials with CIT-013 are expected to … Type: | 0 | 0 | 0 | 25 |
 | FoodStars Turning agri & food tech startups in real stars! FoodStars is challenging the way we feed people in our metropoles. Within and together with this Dutch business ecosystem, accelerators World Startup Factory and Truvalu.startups have joined forces to set up FoodStars. FoodStars is a co-creation and innovation alliance of corporates and startups. Together we aim to bring to the market innovative agtech, horti and food solutions. In this way, we create more responsible production and consumption and contribute to goal #11 of the UN Sustainable Development Goals. business, food, horticulture, startup, agriculture, corporate, sustainability, SDGs, feeding, food production, tech, foostech, … Type: | 0 | 0 | 0 | 6 |
 | Mouvement | 2 | 0 | 1 | 27 |
 | Delft Circuits Delft Circuits provides quantum hardware. With Cri/oFlex®, we introduce a massively scalable i/o solution for quantum. Delft Circuits provides quantum hardware solutions. With the Cri/oFlex® product line, we introduce an ultra-low thermal conductance and massively scalable cryogenic i/o solution, using (super)conducting circuits on flexible substrates. As a service, we design and fabricate custom-engineered (superconducting) quantum circuits and cryogenic instrumentation. superconducting circuits, cryogenic circuit technologies, cryogenic cabling, and cryogenic circuit packaging | 7 | 1 | 6 | 36 |
 | Magnosco GmbH Magnosco GmbH, founded in 2014, is a MedTec Company based in the technology park Berlin-Adlershof. We offer a non-invasive method supporting (early) detection of malignant melanoma based on laser technology. CEO Inga Bergen and COO Thomas Diepold lead the team of scientist and technical experts. Magnosco cooperates with Charité Berlin, University Hospital of Tübingen and the University Hospital of Heidelberg, hospital operator Vivantes and LTB Lasertechnik Berlin regarding the development and certification as a medical device. More and more people know that if skin lesions are changing a doctor’s expertise is very important to detect skin cancer early on. Especially … Type: | 0 | 0 | 0 | 15 |
 | PreOmics SETTING THE STANDARD FOR PROTEIN ANALYSIS PreOmics empowers its clients in life sciences to establish biological knowledge through efficient, reliable solutions and workflows that set the standard for protein analysis. Our team spirit, energy, and commitment empower us to be both creative and quality-focused – A trusted partner with deeply rooted scientific experience.We envisage a future with revolutionary proteomic discovery processes open for everyone. Tools that reveal hidden causes of diseases, ensure sustainable nutrition, and provide diagnoses that enhance lives and society. PreOmics GmbH Am Klopferspitz 19 82152 Planegg/Martinsried Germany Contacts: Telephone: +49-89-2314163-0 Telefax: +49-89-2314163-99 Email: info@preomics.com Privacy Policy: https://www.preomics.com/legal/data-privacy-policy … Type: | 1 | 0 | 1 | 62 |
 | NUMAFERM Biomade Peptides We believe that in the near future peptides have found their way into new markets and are a well-known feed stock for better products in life sciences and beyond. NUMAFERM supports you in these developments – from discovery to commercial production. Type: | 2 | 1 | 2 | 17 |
 | Immunic Therapeutics Immunic is a biotechnology company developing small molecule therapies for chronic inflammatory and autoimmune diseases Immunic (Nasdaq: IMUX) is a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases. Privacy Policy: https://imux.com/privacy-policy/ Type: | 3 | 0 | 3 | 82 |
 | Noscendo GmbH Using #NGS of cell free nucleic acids to identify over a thousand microbes we change the way #pathogens are identified Noscendo GmbH, a Duisburg (Germany) based molecular diagnostics company, changes the way infection causative microbes are identified. Introducing a paradigm shift using proprietary algorithms and software harnessing next generation sequencing of cell free nucleic acids isolated from patient samples Noscendo brings the concept of liquid biopsy into the field of infectious diseases. Noscendo’ s software solution is capable of differentiating infection from non-infectious signals and thereby aiding intensive care clinicians in their daily task to find the right decisions, enabling … Type: | 1 | 1 | 0 | 48 |
 | RAMP.medical Accessible medicine of the highest quality RAMP.medical is a forward-thinking company with three specialized branches. RAMP.consultation offers telemedicine services where doctors, supported by AI, provide thorough and serious patient care. RAMP.ai assists healthcare providers in integrating medical decision support into their daily routines. RAMP.home, in collaboration with partners, is developing an AI-supported elderly care concept to ensure the best care while making people feel truly at home.Already covering endocrinological and cardiological treatments, the software matches patient data with evidence and treatment guidelines, leaving the final decision with the fully informed and AI empowered doctor. Digital Health, Therapy-decision support, ehealth, Clinical … Type: | 4 | 0 | 1 | 4 |
 | Belyntic GmbH The Precision Vaccines Company Belyntic creates novel vaccines for viral diseases with unmet medical need. We have developed and validated a new platform technology, that generates self-adjuvant synthetic long peptides for a safe and durable induction of cellular immunity. Drug development, Cellular immunity, and Platform technology Type: | 1 | 0 | 0 | 2 |
 | IRUBIS Innovative Process Analytical Spectroscopy for Upstream and Downstream Processing IRUBIS | Innovative Process Analytical Spectroscopy for Biomanufacturing. IRUBIS is a company that specializes in mid-infrared (MIR) spectroscopy for bioprocessing. We have designed an instrument, Monipa, specifically for bioprocess monitoring and control. Monipa is based on MIR spectroscopy, making it possible to monitor multiple bioprocesses real-time and continuously. Our instrument's applications are foreseen in both upstream and downstream bioprocessing. These include multiple metabolite monitoring and control in upstream processing. In addition, contaminant detection or monitoring of target proteins and excipients can be aided in downstream processing. Read more about our products … Type: | 5 | 0 | 3 | 18 |
 | Angiolutions We turn science into medicine. Angiolutions – breaking new ground in abdominal aortic aneurysm (AAA) treatment. Abdominal aortic aneurysms are threatening the lives of millions of patients around the world with no way to intercept early disease progression. Angiolutions will change that. Angiolutions is the first company to develop a therapeutic device preventing disease progression in small abdominal aortic aneurysms. Type: | 1 | 0 | 1 | 9 |
 | Sedivention GmbH Devices for therapy and prevention Sedivention develops a break-through, widely applicable, device for interventional obesity therapy. Hunger is transmitted from the stomach to the brain by the gastric trunks of the vagal nerve. Sedivention is developing a cryo-balloon freezing the gastric branches of the vagal nerve from inside the stomach, in a procedure comparable to gastroscopy. The ambulatory intervention takes approximately 20 min. The costs of the intervention are far below costs of bariatric surgery without surgical morbidity and complications. In brief: Sedivention develops the first long-term effective, scalable therapy for obesity: No scars, no pain, no surgical complications, no … Type: | 1 | 1 | 0 | 2 |
 | nanoshape GmbH nanoshape provides a new developed surface treatment for medical implants to reduce bacterial infection nanoshape is a German start-up with the mission to prevent implant-infections with innovative nanotechnology. Implant surfaces play a major role in implant anchorage and implant compatibility. Currently available implant systems usually have sandblasted and etched surfaces to enhance osseointegration (integration into surrounding bone tissue). In some cases functional coatings with other materials are applied. However, hardly any commercial implant systems have surfaces that can reduce the bacterial colonization. We have developed an innovative surface treatment that gives implants bacteria repellent properties. In this process, the topography … Type: | 1 | 1 | 1 | 3 |
 | AbCheck s.r.o. Meeting Your Needs in Cutting-edge Antibody Discovery and Development AbCheck discovers and optimizes human therapeutic antibodies with one of the industry’s most versatile technology platforms. Tailored to specific needs and desired Target Product Profiles, AbCheck leverages both cutting-edge (e.g., microfluidics, rabbit mass humanization) and state-of-the-art (e.g., phage/yeast display libraries) technologies to provide high quality leads. The company has proven its capabilities in multiple partnerships throughout the U.S. and Europe. AbCheck is a wholly-owned subsidiary of Ampersand Biomedicines, a Flagship Pioneering Company. Type: | 0 | 0 | 0 | 26 |
 | TetraKit Technologies Next Generation Theranostics TetraKit Technologies (2021) is a spin-off company originating from the University of Copenhagen (KU). Our mission is to revolutionize theranostic agent development through our unique chemistry - The TetraKit Platform. It allows for one-fits-all radiolabeling of most targeting vectors with optimal diagnostic and therapeutic radionuclides. We develop both, our core platform technology, as well as proprietary novel theranostic radiopharmaceuticals based on our platform. This technology is based on the latest advancements in click chemistry and radiolabeling techniques coming from our laboratories. We are interested in partnerships to combine our radiolabeling platform with emerging targeting vectors. Radiopharmaceuticals, Nuclear … Type: | 1 | 1 | 0 | 97 |
 | POROUS Quantitative Ultrasound Based Cortical Bone Microstructure Analysis Osteoporosis accounts for more days in the hospital than breast cancer, heart attack, diabetes, and other diseases. Due to this fact, the cost that osteoporosis imposes on healthcare budgets is staggering. In 2010, European Union countries spent €37 billion (US$40 billion), while in 2015, the United States spent US$20 billion, a staggering total annual cost of US$60 billion and growing. Current measurement methods cannot detect the onset of osteoporosis but rather approximate the bone-loss associated relative fracture risk, typically at advanced stages of the disease progression. Early detection is vital because the highest … Type: | 3 | 1 | 2 | 15 |
 | DeepEn We build hair-thin microscopes for neuroscience and medicine. DeepEn offers hair-thin endomicroscopy solutions capable of subcellular resolution and high-speed observations within hard-to-access body regions. Our minimally invasive devices are used in research and diagnostics, helping to advance our understanding of diseases and microscopic processes deep inside sensitive tissues in real time. DeepEn was founded in 2024 as a spinoff from the Department for Holographic Endoscopy, led by Prof Dr Tomas Cizmar at Leibniz Institute of Photonic Technology in Jena, Germany. Our Managing Director is Dr Sergey Turtaev. For more information, visit deepenimaging.com | 2 | 1 | 1 | 4 |
 | Acorai The new standard in heart failure management Acorai is developing a device for heart failure management through non-invasive intracardiac pressure monitoring (ICPM), to help reduce hospitalizations and readmissions. Our product can monitor intracardiac pressures non-invasively through a machine learning analysis of pressure dynamics in acoustics, vibratory and waveform data. Our technology show compelling precision, has a low-risk clinical and regulatory pathway, a low dependence on reimbursement and a fast track to commercialization. Cardiology, Heart Failure, Heart Failure Monitoring, Non-invasive intracardiac pressure monitoring, Medical Device, AI, Machine Learning, Heart Failure Patient Workflow, ICPM, Prevent heart failure readmissions, Multi-sensor hardware, Pressure dynamics, … Type: | 7 | 3 | 3 | 25 |
 | Rebiotix Inc (a Ferring Company) A Ferring Company working to harness the power of the human microbiome to address unmet medical needs. Rebiotix Inc, part of the Ferring Pharmaceuticals Group, is a clinical-stage biotechnology company revolutionizing the treatment of challenging gastrointestinal diseases by harnessing the power of the human microbiome. Our highly skilled and dynamic team is based out of Roseville, Minnesota. Please feel free to contact us through our website at www.rebiotix.com. Biotechnology, Microbiome, Drug Development, Medicine, Clinical Trials, Regulatory Innovation, Patient Support, Internal Medicine, Manufacturing, Infectious Disease, Gastroenterology, Emerging Diseases, and Novel Technology Type: | 0 | 0 | 0 | 90 |
 | ConcertAI Accelerating insights and outcomes for patients through leading RWD, AI technology and scientific expertise. The fastest growing AI-powered SaaS data company in healthcare. Real World Data, Precision Medicine, RWE, Artificial Intelligence, biopharma, Clinical Trials, Real World Evidence, SaaS, Patient Access, Patient Outcomes, Patient Insights, Technology, Scientific Expertise, Biomedical Innovators, Leading RWE, Clinical Development, and Enterprise Data Type: | 8 | 0 | 8 | 929 |
 | Applied BioMath Model-Informed Drug Discovery and Development (MID3) services, software, and R&D company. Founded in 2013, Applied BioMath uses mathematical modeling and simulation to provide quantitative and predictive guidance to biotechnology and pharmaceutical companies to help accelerate and de-risk drug research and development. Our Model-Aided Drug Invention (MADI) approach employs proprietary algorithms and software to support groups worldwide in decision-making from early research through clinical trials. The Applied BioMath team leverages their decades of expertise in biology, mathematical modeling and analysis, high-performance computing, and industry experience to help groups better understand their candidate, its best-in-class parameters, competitive advantages, patients, and the best … Type: | 1 | 0 | 0 | 38 |
 | CTTI Mission: Develop & drive adoption of practices that increase quality/efficiency of #ClinicalTrials. Follows/RTs ≠ endorsements #InnovationThroughCollaboration | 0 | 0 | 0 | N/A |
 | Karyopharm Therapeutics Inc. Discovers, develops and commercializes novel, life-changing cancer therapies in disease areas with high unmet need. Karyopharm Therapeutics Inc. is a commercial-stage pharmaceutical company whose dedication to pioneering novel cancer therapies is fueled by a belief in the extraordinary strength and courage of patients with cancer. As an organization, Karyopharm is on a mission to improve lives and defeat cancer. In its role as leaders in XPO1 inhibition, Karyopharm delivers on its mission by creating a focused pipeline that targets multiple high unmet need cancer indications, including multiple myeloma, endometrial cancer, myelofibrosis, and diffuse large B-cell lymphoma (DLBCL). oncology, pharmaceutical, biotech, … Type: | 4 | 0 | 1 | 399 |
 | Nanna Therapeutics Totally Integrated Medicines Engine (TIME) to Cure Diseases Type: | 0 | 0 | 0 | N/A |
 | Oncoheroes Biosciences A Biotech Company 100% Focused On Advancing New Therapies For Childhood Cancer A life science company exclusively focused on finding cures for childhood cancer by identifying and developing the most promising projects to create new treatments and drugs. drug development, clinical development, and childhood cancer Type: | 4 | 0 | 2 | 11 |
 | Vicore Pharma AB Vicore is an innovative clinical-stage pharmaceutical company unlocking the potential of a new class of drugs with disease-modifying potential. The company is establishing a portfolio in respiratory diseases, including idiopathic pulmonary fibrosis (IPF). Buloxibutid (C21) is a first-in-class orally available small molecule angiotensin II type 2 receptor agonist (ATRAG) currently in phase 2a development for IPF. AlmeeTM (an investigational medical device in clinical development) is a digital therapeutic based on cognitive behavioral therapy created to address the psychological impact of living with pulmonary fibrosis. Almee has received Breakthrough Device Designation from the FDA, reflecting its potential to have transformative impact. … Type: | 0 | 0 | 0 | 39 |
 | PhoreMost Ltd Drugging the Undruggable® PhoreMost is a new-model drug discovery company based in Cambridge, UK. We are dedicated to ‘Drugging the Undruggable®’ disease targets using our next-generation technology, SITESEEKER®. Using PROTEINi® libraries, this unique drug target identification platform can discern the best new targets for future therapy and crucially, how to drug them, which has the potential to significantly increase the diversity and affordability of novel therapeutics for cancer and other unmet diseases. PhoreMost is building a pipeline of novel drug discovery programmes aimed at addressing a range of diseases, with a mission to accelerate, diversify and rationalise drug discovery. Using … Type: | 4 | 0 | 1 | 56 |
 | Trutino Biosciences ON DEMAND CYTOKINE Company Trutino means ‘Balance’ in Latin, and this represents our strategy, namely an Rx/Dx approach for Precision Oncology Drug & Clinical Development. The company logo symbolizes well balanced wings. As it takes both wings to fly, we believe a balanced Rx/Dx drug development will ultimately deliver on the promise of Precision Oncology. Our effort focuses on ‘targeted destruction of cancer cells’ and simultaneous ‘differential activation of tumor-specific immune cells’ to maximize treatment response. ON DEMAND CYTOKINE, CYTOKINE DRUG, IMMUNO-ONCOLOGY, and TARGETED ONCOLOGY Type: | 0 | 0 | 0 | 16 |
 | Enterprise Therapeutics Dedicated to the development of novel therapies to improve the lives of patients with respiratory disease Enterprise Therapeutics is a drug discovery company dedicated to the research and development of novel therapies for the treatment of respiratory diseases. In diseases such as cystic fibrosis, asthma and COPD the lungs become congested with mucus leading to difficulty in breathing. New disease modifying therapies that target the underlying mechanisms of mucus congestion will reduce the frequency of lung infections and improve patient quality of life. The leadership team has significant expertise in drug discovery, drug development, respiratory biology and ion channel pharmacology. … Type: | 1 | 1 | 1 | 12 |
 | Biognosys Transforming life sciences with cutting-edge proteomics technology and solutions The decoding of the proteome is revolutionizing the way diseases are diagnosed, treated, and prevented. Biognosys invents and provides patented proteomics solutions at the quality, scale, and speed required to transform R&D, clinical trials, and clinical decision making. Our Solutions We offer a versatile portfolio of proprietary proteomics services, software, and kits. We make these widely available for pharmaceutical and biotechnology researchers and proteomics experts. Our solutions provide a multi-dimensional view of protein expression, function, and structure in all major sample types – cells, tissues, or body fluids – across human … Type: | 4 | 0 | 4 | 90 |
 | T3 Pharmaceuticals AG Developing the next generation bacterial cancer therapy Developing the next generation bacterial cancer therapy The vision of T3 Pharmaceuticals is to improve the lives of cancer patients with highly innovative treatments. Despite significant advances of classical therapies, there remains a high need for novel and innovative medicines to treat cancer. T3 Pharmaceuticals is dedicated to fill this gap by developing highly specific and efficient treatments using live bacteria. T3 Pharmaceuticals was founded in May 2015 by Simon Ittig, Christoph Kasper, Marlise Amstutz and Helmut Kessmann as a spin-off of the University of Basel. The team has developed an efficient protein … Type: | 1 | 1 | 0 | 24 |
 | BiomX Inc Customized phage therapies to eradicate harmful bacteria in chronic diseases BiomX is developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as cystic fibrosis, inflammatory bowel disease, atopic dermatitis and colorectal cancer. BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets. Microbiome, Biotechnology, Drug Discovery, and Phage Therapies Type: | 1 | 0 | 1 | 70 |
 | Cognito Therapeutics, Inc. Cognito Therapeutics is a pioneer in non-invasive neuromodulation to treat neurodegenerative diseases. Cognito Therapeutics is a pioneer in non-invasive neuromodulation to treat neurodegenerative diseases and improve human cognitive performance. The company has completed multiple clinical studies demonstrating its investigational therapeutic has the potential to safely slow or stop cognitive decline and loss of brain volume in Alzheimer’s disease. Cognito has received FDA Breakthrough Device Designation for the treatment of Alzheimer’s disease and expects to start pivotal studies in 2022. The company’s technology was based on pioneering optogenetics research by scientific co-founders Professors Li-Huei Tsai and Ed Boyden at MIT. Type: | 7 | 0 | 3 | 52 |
 | Kymera Therapeutics Inventing a new class of medicines using Targeted Protein Degradation Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients’ lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on delivering oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Kymera is also progressing degrader oncology programs that target undrugged … Type: | 3 | 0 | 2 | 206 |
 | SOLNATIDE project H2020 project exploring safety, tolerability and clinical efficacy of solnatide IMP in COVID-19 patients. The SOLNATIDE project will clinically test the safety, tolerability and clinical efficacy of solnatide IMP in patients with severe COVID-19 requiring mechanical ventilation. APEPTICO’s lead-compound solnatide IMP has been designed for the therapeutic treatment of patients with Acute Respiratory Distress Syndrome (ARDS) and various forms of Pulmonary Oedema (PPO). Orally inhaled solnatide has delivered clinical proof-of-concept in one Phase I and two Phase IIa clinical studies (EUDRACT No. 2011-000223-33, 2012-001863-64 and 2013-000716-21). Currently, solnatide is subject to a Phase IIB trial (EUDRACT No. 2017-003855-47) being approved … Type: | 0 | 0 | 0 | N/A |
 | Proxygen The Art of Glue Hunting A curious team of explorers, deeply rooted in science, and constantly on the lookout for a very particular novel drug modality. This is us – Proxygen. We hunt for glue degraders. They are the key to unlocking new treatments for patients. They revolutionize how we see and cure diseases. Type: | 1 | 0 | 0 | 37 |
 | OXGENE A WuXi Advanced Therapies company, based in Oxford, UK. OXGENE, a WuXi Advanced Therapies (WuXi ATU) company, based in Oxford, UK, provides cell and gene therapy pioneers around the world with the technologies, automation platforms and service solutions they need to come first in the race to deliver ground-breaking therapeutics. OXGENETM is headquartered in Oxford, UK. For additional information, please visit our website. PRODUCTS: Largest collection of standardised plasmids on the market and SERVICES: DNA Services, Protein Production Services, Virus Services, Cell Line Development Services. Type: | 3 | 0 | 0 | 58 |
 | ASCIL Biopharm We make injectable products better Ascil Biopharm is a Drug Delivery System company specialized in Long Acting Injectables (LAI) and devices. Our Research and development is focused in Controlled Release Formulations (CRF) and precision medical devices to enhance efficiency, safety, and patient convenience. Controlled Release Formulations, Long Acting Injectables, Drug Delivery Systems, and Parenteral Type: | 0 | 0 | 0 | 26 |
 | Enara Bio Advancing cancer immunotherapy by targeting the unconventional Enara Bio is shining a light on Dark Antigen® and T-cell biology to develop cancer immunotherapies designed to improve treatment outcomes for broad populations of cancer patients. Our pioneering EDAPT® platform enables us to discover novel cancer-specific antigens from previously uncharted genomic ‘dark matter’. The result is a growing database of Dark Antigens that can address the unmet need for cancer-specific targets that are homogenously expressed and highly prevalent in solid tumors. We are advancing multiple approaches to exploit these Dark Antigen targets, with an internal focus on TCR-directed immunotherapies, and additional therapeutic … Type: | 6 | 1 | 3 | 61 |
 | Axonis Therapeutics Axonis Therapeutics is advancing breakthrough discoveries to develop first-in-class therapies for neurological disorders Axonis Therapeutics is a Boston-based, neuro-focused biotechnology company developing first- and best-in-class medicines targeting KCC2, the critical mediator of inhibition within the brain, by translating breakthrough discoveries spun out from Boston Children’s Hospital, Harvard and Laval University. We are an exceptional team of drug hunters and target biology experts who have built a proprietary KCC2 discovery engine based on several years of world-leading know-how, to become the leaders in this potential blockbuster drug space. A venBio portfolio company, Axonis has raised $34+M in dilutive Seed funding, and … Type: | 6 | 0 | 3 | 19 |
 | Gubra Science of certainty Founded in 2008, we are a biotech company with two primary areas of business: Preclinical contract research organization (CRO) services and proprietary early target and drug discovery programs. Our focus is the metabolic space (e.g. obesity, diabetes, NASH and gastrointestinal diseases), where we specialize in peptide chemistry, in vivo pharmacology, ex vivo assays, molecular pharmacology, histology, imaging, stereology, NGS (next generation sequencing) and bioinformatics. Gubra is an abbreviation for GUt and BRAin, the original key focus areas of our research and expertise. We work with some of the most interesting and loyal partners and customers from across … Type: | 2 | 0 | 2 | 257 |
 | ArtiQ Providing AI software to optimize clinical trials and enhance diagnostic processes to improve patients' lives worldwide ArtiQ, a spin-off from the Belgian university KU Leuven, is a leading innovative software company dedicated to enhancing the diagnosis and monitoring of patients with respiratory conditions. Moreover, ArtiQ strives to streamline and optimize respiratory clinical trials for pharmaceutical companies. Through the development and provision of cutting-edge AI-first software, ArtiQ empowers traditional respiratory devices and processes. In April 2024, ArtiQ joined forces with Clario, a leading healthcare research and technology company. This collaboration allows ArtiQ to broaden its reach globally across various clinical trials … Type: | 7 | 1 | 4 | 25 |
 | G1 Therapeutics, Inc. Our mission is to discover, develop and deliver next generation cancer therapies. G1 Therapeutics, Inc. is a commercial-stage oncology company focused on the development and commercialization of next generation anti-cancer therapies. Led by a team with a deep understanding of the biology of cancer and extensive development and commercialization expertise, G1 is advancing its mission to improve the lives of those affected by cancer, including by commercializing the Company’s first commercial product, COSELA® (trilaciclib). G1 is also executing a development program, with a deep clinical pipeline evaluating targeted cancer therapies in a variety of solid tumors, including breast, lung, and … Type: | 1 | 0 | 0 | 88 |
 | Biome Diagnostics Advancing cancer care through microbiome profiling 🦠 Discover your microbiome: www.mybioma.com Biome Diagnostics GmbH (BiomeDx®) is an Austrian based MedTech company committed to advance precision medicine by pioneering microbiome-based technologies that transform cancer care. The company is strategically positioned at the intersection of state-of-the-art DNA sequencing and advanced machine learning algorithms to develop first in class technologies for routine clinical practice. Additionally to the lifestyle product myBioma (www.mybioma.com) for end-customers, the company focuses on the development of medically certified products in the area of gut microbiome and cancer. As safety and health of patients are top priorities, the company has … Type: | 4 | 0 | 3 | 17 |
 | PIUR IMAGING GmbH Taking your ultrasound to the next dimension PIUR IMAGING, an Austrian medtech company, which is active in the field of diagnostic ultrasound imaging and is specialized in acquisition and visualization of 3D ultrasound images. PIUR IMAGINGs vision is it to provide access to affordable high-quality healthcare through AI-driven tomographic ultrasound solutions – everywhere! PIUR ́s tomographic ultrasound solution PIUR tUS Infinity turns any standard ultrasound system into a tomographic 3D imaging device, enabling true AI in ultrasound. With any conventional 2D ultrasound transducer, high-resolution tomographic images can be generated. While standard ultrasound requires on-the-spot assessment of the images, PIUR ́s … Type: | 0 | 0 | 0 | 36 |
 | Delta4ai Delta4 is a Vienna-based biotech startup driving the forefront of digital drug discovery and development. Delta4 is driving the forefront of digital drug discovery and development. We leverage a proprietary computational analytics platform "Hyper-C", combining straightforward biomedical testing and clinical validation of candidate drugs. Our unique approach integrates iterative big data/in silico and experimental screens, offering the most efficient matching of clinical indications and compound/drug effects. drug repositioning, drug discovery, compounds, orphan diseases, indication expansion, AI, and omics Type: | 4 | 0 | 0 | 11 |
 | a:head bio AG we aim to develop new therapeutics for the treatment of brain disorders based on human cerebral organoids a:head’s drug discovery approach is based on human cerebral organoids, a revolutionary, paradigm-shifting new technology that allows the generation of mini brains from human stem cells in vitro. They capture the essential aspects of human embryonic brain development including brain patterning, formation of brain ventricles, differentiation into the various neuronal and supportive cell types and their correct three-dimensional arrangement. The technology has been pioneered by the company’s co-founders Madeline Lancaster and Juergen Knoblich and is exclusively licensed to a:head by the Institute of … Type: | 2 | 0 | 1 | 18 |
 | Nanoform Global experts in nanotechnology and drug particle engineering Nanoform is an innovative nanoparticle medicine enabling company. Nanoform works together with pharma and biotech partners globally to provide hope for patients in developing new and improved medicines utilizing Nanoform’s platform technologies. The company focuses on reducing clinical attrition and on enhancing drug molecules’ performance through its nanoforming technologies and formulation services. Nanoform’s capabilities include GMP manufacturing, and its services span the small to large molecule development space with a focus on solving key issues in drug solubility and bioavailability and on enabling novel drug delivery applications. Type: | 10 | 0 | 4 | 162 |
 | Enanta Pharmaceuticals Our vision is to transform the lives of patients with curative therapies. Enanta is using its robust, chemistry-driven approach and drug discovery capabilities to become a leader in the discovery and development of small molecule drugs for virology and immunology indications. Enanta’s research and development programs are currently focused on respiratory syncytial virus (RSV) and chronic spontaneous urticaria (CSU) and the company has previously advanced clinical-stage compounds for SARS-CoV-2 (COVID-19) and chronic hepatitis B virus (HBV) infection. Glecaprevir, a protease inhibitor discovered by Enanta, is part of one of the leading treatment regimens for curing chronic hepatitis c virus (HCV) … Type: | 2 | 0 | 2 | 160 |
 | Terns Pharmaceuticals Taking the Journey Towards Comprehensive Treatment of Serious Disease Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline includes three clinical-stage development programs including an allosteric BCR-ABL inhibitor, a small-molecule GLP-1 receptor agonist, a THR-β agonist and preclinical GIPR modulator programs. For more information, please visit: www.ternspharma.com. Disclaimer: Reposts and posts of contents are for informational purposes only and do not constitute endorsements or promotions of any third-party products, services or organizations (including any statements, views or conducts by such organizations) unless explicitly stated … Type: | 0 | 0 | 0 | 63 |
 | Sixfold Bioscience RNA delivery, evolved. RNA delivery, evolved. Drug delivery, RNA, and RNA delivery Type: | 4 | 0 | 3 | 33 |
 | Kineta KA (Nasdaq) Developing next-generation immunotherapies for cancer patients! Kineta is a clinical stage biotechnology company with a mission to develop next-generation immunotherapies that transform patients’ lives. Antivirals, Chronic Pain, Immuno-oncology, Biodefense, Immunology, Virology, Lassa fever, and Neuroscience | 4 | 0 | 3 | 29 |
 | Alto Neuroscience Precision medicine for the brain is here. Alto Neuroscience is redefining psychiatry by leveraging individuals' neurobiology to develop personalized and highly effective medicines, helping patients get better faster. Alto's Precision Psychiatry PlatformTM measures biomarkers like EEG and wearable data, behavioral patterns, genetics, and other factors to match patients with the treatment they are most likely to respond to. Our approach matches the right patient with the right Alto drug based on AI-derived brain biomarkers, redefining psychiatry at a time when the world needs it most. Type: | 3 | 0 | 3 | 87 |
 | Karuna Therapeutics Pushing the boundaries of neuroscience to transform the treatment of mental illness. Karuna Therapeutics, Inc. is now part of Bristol Myers Squibb. Learn about how we are continuing to transform the lives of patients with neurological and neuropsychiatric diseases @Bristol Myers Squibb or www.bms.com. Type: | 4 | 1 | 4 | 133 |
 | ZS | Intomics ZS | Intomics is a highly specialized biomedical data analytics company. We derive core biological insights from analysis and integration of biomedical big data. We increase the success rate of drug discovery and development projects for clients in the pharmaceutical industry. With our world-leading expertise, unique value-added data sets and sophisticated systems biology platform, we help our clients with: • Discovering new biomarkers • Assessing the specificity of biomarkers • Linking biomarkers to the underlying biology • Identifying drug targets and MOA • Delivering personalized medicine solutions • Repositioning of drugs • Creating biological knowledge maps for data-driven decision-making To … Type: | 3 | 1 | 1 | 28 |
 | InterAx Biotech Advanced integration of biological systems, math models and artificial intelligence The company, a spin-out of ETH Zurich and the Paul Scherrer Institute, Switzerland, uses high throughput biochemical screening of compounds integrated into an artificial intelligence and cell pathways mathematical modeling process. This platform unlocks previously intractable targets, shortens timelines for drug discovery from years to months and reduces risks. The company focuses on the generation and optimization of drugs which trigger a specific and well characterized effect on signaling pathways, thus leading to higher therapeutic efficacy and reduced risk of toxicity. The company is specialized in GPCR drug discovery and … Type: | 4 | 0 | 3 | 17 |
 | ArrePath Deciphering biology, discovering new classes of anti-infectives. ArrePath is a biotech company discovering and developing new and differentiated classes of anti-infectives to address antimicrobial resistance (AMR) through the application of state of the art technologies and novel strategies. We apply world-class science and innovation in imaging and AI / ML technologies to identify and develop novel drugs to address global health issues. Our advanced machine learning (ML) and imaging-based drug discovery platform enables a rapid and efficient identification of new drug classes with desired activity profiles and clinical utility, coupled with a deep understanding of mechanism of action at the … Type: | 1 | 0 | 1 | 18 |
 | DeNovix Inc. We design, manufacture and sell award-winning lab equipment for today's life scientists. DeNovix Inc., founded in 2012, is a Wilmington, DE, USA based instrumentation company that develops, manufactures and sells laboratory equipment to meet the demands of today’s evolving life science research. DeNovix focuses on providing innovative products and outstanding customer support. The company is equipped with the financial, commercial and technical resources to deliver breakthrough products for research success. DeNovix products include the DS-11 Series Spectrophotometer / Fluorometer, the CellDrop Automated Cell Counter, the QFX Fluorometer and DeNovix assays. Our instruments are stand-alone (no PC needed) and built on … Type: | 1 | 0 | 1 | 27 |
 | PHC Corporation of North America Life Science Innovator Since 1966 PHC Corporation of North America (PHCNA) is headquartered in Wood Dale, IL and manufactures and markets PHCbi brand laboratory equipment. PHCNA is a subsidiary of PHC Holdings Corporation of Tokyo, Japan, a global diversified life sciences, diagnostics, and medical device company. For more than 50 years, PHCNA has met the needs of pharmaceutical, biotechnology, hospital/clinical, and industrial customers, offering a unique perspective on scientific research. We play a critical role in global product development across a range of research areas and have a deeply entrenched reputation as a manufacturer of highly-reliable quality and innovative laboratory … Type: | 3 | 0 | 0 | 203 |
 | SCARLETRED Holding GmbH SCARLETRED is the leading expert in AI assisted skin monitoring and objective image analysis SCARLETRED is a MedTech company transforming the global dermatology market. Our CE approved medical device platform Scarletred®Vision is the first AI powered skin image analysis software supplied to Biopharma, Health Care and Cosmetics Industry enabling to develop better products much faster. The patented technology facilitates standardized skin documentation and remote tracking via mobile App. Images can be uploaded in a cloud based platform and objectively analyzed for visual skin changes over time, such as for allergic reactions, pigmentation changes, acne, psoriasis or wound healing. The application … Type: | 0 | 0 | 0 | 17 |
 | Platomics The Industry Accelerator for In Vitro Diagnostics Innovation to patient, faster Platomics enables in vitro diagnostic manufacturers and laboratories to bring safe and effective innovations to market with unparalleled speed and efficiency. Our global platform for generating and marketing compliant IVD products is equipped with intelligent regulatory automation that allows our clients to seamlessly overcome regulatory challenges over the entire life cycle of their products. Personalized Medicine, Next Generation Sequencing, Infrastructure Provider, Artificial Intelligence, Software Developer, Bioinformatics, and Cloud Computing | 1 | 0 | 1 | 100 |
 | invIOs INNOVATIVE IMMUNO-ONCOLOGY Developing tomorrow's cancer therapies. Today. invIOs is a private biotech company focusing on discovery and development of novel cancer therapeutics that empower and educate the immune system to fight cancer. We leverage our deep expertise in immune-system activation to advance a focused pipeline of individualized and targeted approaches against solid tumors. Our focus is on earlier-stage development, with a sweet spot in bringing assets through discovery and pre-clinical development and into clinical trials. We launched in 2022 as a spin-out bundling the innovative oncology assets of APEIRON Biologics. Our highly motivated team of 35 people has deep expertise across the … Type: | 1 | 0 | 0 | 24 |
NGO, Think-tanks, Ed, & Culture